Global Implantable Cardiac Rhythm Management (crm) Devices Market Size & Outlook
Global implantable cardiac rhythm management (crm) devices market, 2018-2030 (US$M)
Related Markets
Global implantable cardiac rhythm management (crm) devices market highlights
- The global implantable cardiac rhythm management (crm) devices market generated a revenue of USD 10,133.1 million in 2023 and is expected to reach USD 15,530.6 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.3% by 2030.
- In terms of segment, cardiac resynchronization therapy (crt) accounted for a revenue of USD 4,456.7 million in 2023.
- Implantable Cardioverter Defibrillators (ICDs) is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 10,133.1 million |
| Market revenue in 2030 | USD 15,530.6 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Cardiac resynchronization therapy (crt) |
| Fastest growing segment | Implantable Cardioverter Defibrillators (ICDs) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers |
Other key industry trends
- In terms of revenue, the North America accounted for 47.6% of the global implantable cardiac rhythm management (crm) devices market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 109.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardiac Rhythm Management (CRM) devices market Scope
Implantable Cardiac Rhythm Management (CRM) devices market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ZOLL Medical Corporation | View profile | 1001-5000 | Chelmsford, Massachusetts, United States, North America | http://www.zoll.com/ |
| SCHILLER | View profile | 501-1000 | Feldkirchen, Bayern, Germany, Europe | https://www.schillermed.de/ |
| MicroPort Scientific Corp | View profile | 8230 | 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 | https://www.microport.com |
| BIOTRONIK | View profile | 5001-10000 | Berlin, Berlin, Germany, Europe | https://www.biotronik.com/de-de |
| Nihon Kohden Corp | View profile | 6325 | 31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo, Japan, 1618560 | http://www.nihonkohden.co.jp |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global implantable cardiac rhythm management (crm) devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardiac rhythm management (crm) devices market will help companies and investors design strategic landscapes.
Cardiac resynchronization therapy (crt) was the largest segment with a revenue share of 43.98% in 2023. Horizon Databook has segmented the Global implantable cardiac rhythm management (crm) devices market based on cardiac resynchronization therapy (crt), implantable cardioverter defibrillators (icds), pacemakers covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Implantable Cardiac Rhythm Management (CRM) devices Product Outlook (Revenue, USD million, 2018-2030)
- Implantable Cardioverter Defibrillators (ICDs)
- Single Chamber ICDs
- Dual Chamber ICDs
- Pacemakers
- Conventional Pacemakers
- Leadless Pacemaker
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemaker
- Implantable Cardioverter Defibrillators (ICDs)
- Global Implantable Cardiac Rhythm Management (CRM) devices End Use Outlook (Revenue, USD million, 2018-2030)
- Specialty Cardiac Centers
- Others
- Hospitals
Reasons to subscribe to Global implantable cardiac rhythm management (crm) devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global implantable cardiac rhythm management (crm) devices market databook
-
Our clientele includes a mix of implantable cardiac rhythm management (crm) devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global implantable cardiac rhythm management (crm) devices market, including forecasts for subscribers. This global databook contains high-level insights into Global implantable cardiac rhythm management (crm) devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global implantable cardiac rhythm management device market size, by regions, 2018-2030 (US$M)
Top 10 countries: Implantable cardiac rhythm management device market size, 2023 (US$M)
Global implantable cardiac rhythm management device market share, by end use, 2023 & 2030 (%, US$M)
Implantable cardiac rhythm management (crm) devices market: Opportunity assessment by country
Global implantable cardiac rhythm management (crm) devices market, by region, 2023 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
